Stock Screener App

Gratuito -

Installare

12.69

2.23% -0.29

Entrada Therapeutics Inc (TRDA)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Entrada Therapeutics Inc Azioni (TRDA) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	19.52% 1.299	1.614	1.95	20.56	19.57
Operating Expenses	10.60% 43.51	48.66	48.80	42.35	41.23
Benefits Costs and Expenses	-	-	-	37.91	-
Costs And Expenses	10.60% 43.51	48.66	48.80	37.91	41.23
Operating Income/Loss	10.29% -42.21	-47.05	-46.85	-21.79	-21.66
Income/Loss From Continuing Operations Before Tax	19.52% 1.299	1.614	-43.10	-17.35	19.57
Income Tax Expense/Benefit	85.93% 0.092	0.654	0.178	-	-1.86
Income/Loss From Continuing Operations After Tax	11.26% -39.16	-44.13	-43.10	-17.35	-14.03
Net Income/Loss	11.26% -39.16	-44.13	-43.10	-17.35	-14.03
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.81% 0.0784	41.46	41.34	41.07	40.63
Diluted Average Shares	99.81% 0.0784	41.46	41.34	41.07	40.63
Basic Earnings Per Share	11.32% -0.94	-1.06	-1.04	-0.42	-0.35
Diluted Earnings Per Share	11.32% -0.94	-1.06	-1.04	-0.42	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters